CLAIRE HIGGINBOTHAM: Open Payments
NPI 1346993185 · DAYTON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$567 in 35 payments from 11 companies in 2025. Trend: 2023 $375 · 2024 $333 · 2025 $567
Food & beverage: $567
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $173 |
| ABBVIE INC. | 5 | $95 |
| Lilly USA, LLC | 4 | $73 |
| Novo Nordisk Inc | 2 | $52 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
| Viatris Specialty LLC | 2 | $31 |
| Amgen Inc. | 1 | $30 |
| Lundbeck LLC | 1 | $22 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
Products named: CAPLYTA, VRAYLAR, REXULTI, JARDIANCE, Ozempic, YUPELRI, REPATHA, ZEPBOUND.
Industry payments across TN — which companies pay providers there.
